Nextage Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY
Period Ending	Sep '25 Sep 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26	24	-	-	-	-
Enterprise Value	26	24	-	-	-	-
Last Close Price	0.78	0.79	0.34	0.58	2.21	3.09
PS Ratio	63.56	57.53	-	-	-	-
PB Ratio	-4.74	-4.29	-	-	-	-
EV/Sales Ratio	63.41	57.99	-	-	-	-
Debt / Equity Ratio	-0.04	-0.04	-0.14	-0.78	-	0.58
Asset Turnover	0.57	0.57	0.67	-	-	-
Quick Ratio	0.05	0.05	0.24	0.75	-	1.67
Current Ratio	0.05	0.05	0.24	0.80	-	1.67
Return on Assets (ROA)	-296.88%	-296.88%	-191.17%	-	-	-
Return on Capital Employed (ROCE)	62.50%	62.50%	151.50%	2248.10%	-	-249.30%
Earnings Yield	-12.51%	-13.82%	-	-	-	-
FCF Yield	-	-3.35%	-	-	-	-
Buyback Yield / Dilution	-12.68%	-12.68%	-4.79%	-6.98%	-127.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.